WCM
IDXX icon

Wallace Capital Management’s Idexx Laboratories IDXX Stock Holding History

Wallace Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-350
Closed -$237K – 78
2025
Q4 		$237K Hold
350
– – 0.03% 70
2025
Q3 		$224K Buy
+350
New +$212K 0.03% 71

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wallace Capital Management's IDXX Position: Q1 2026 in Review

Wallace Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 350 shares — an estimated $237K sold.

Wallace Capital Management first reported a position in IDXX in Q3 2025 and held it in 2 quarters. The position peaked at $237K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Wallace Capital Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Wallace Capital Management sold 350 Idexx Laboratories shares in Q1 2026, an estimated $237K.
  • Wallace Capital Management first reported a position in Idexx Laboratories in Q3 2025 and held it in 2 quarters.
  • Wallace Capital Management's Idexx Laboratories position peaked at $237K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Wallace Capital Management's 13F filing for Q1 2026, filed 15 May 2026.